|
1
|
Bedkowska GE, Ławicki S and Szmitkowski M:
Molecular markers of carcinogenesis in the diagnostics of cervical
cancer. Postepy Hig Med Dosw (Online). 63:99–105. 2009.(In Polish).
PubMed/NCBI
|
|
2
|
Rajkumar T, Sabitha K, Vijayalakshmi N,
Shirley S, Bose MV, Gopal G and Selvaluxmy G: Identification and
validation of genes involved in cervical tumourigenesis. BMC
Cancer. 11:802011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hu X, Schwarz JK, Lewis JS Jr, Huettner
PC, Rader JS, Deasy JO, Grigsby PW and Wang X: A microRNA
expression signature for cervical cancer prognosis. Cancer Res.
70:1441–1448. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ma YY, Wei SJ, Lin YC, Lung JC, Chang TC,
Whang-Peng J, Liu JM, Yang DM, Yang WK and Shen CY: PIK3CA as an
oncogene in cervical cancer. Oncogene. 19:2739–2744. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Su TH, Chang JG, Perng LI, Chang CP, Wei
HJ, Wang NM and Tsai CH: Mutation analysis of the putative tumor
suppressor gene PTEN/MMAC1 in cervical cancer. Gynecol Oncol.
76:193–199. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ben-Baruch A, Michiel DF and Oppenheim JJ:
Signals and receptors involved in recruitment of inflammatory
cells. J Biol Chem. 270:11703–11706. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cyster JG: Chemokines and the homing of
dendritic cells to the T cell areas of lymphoid organs. J Exp Med.
189:447–450. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cyster JG: Chemokines and cell migration
in secondary lymphoid organs. Science. 286:2098–2102. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Luboshits G, Shina S, Kaplan O, Engelberg
S, Nass D, Lifshitz-Mercer B, Chaitchik S, Keydar I and Ben-Baruch
A: Elevated expression of the CC chemokine regulated on activation,
normal T cell expressed and secreted (RANTES) in advanced breast
carcinoma. Cancer Res. 59:4681–4687. 1999.PubMed/NCBI
|
|
10
|
Mrowietz U, Schwenk U, Maune S, Bartels J,
Küpper M, Fichtner I, Schröder JM and Schadendorf D: The chemokine
RANTES is secreted by human melanoma cells and is associated with
enhanced tumour formation in nude mice. Br J Cancer. 79:1025–1031.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Robinson SC, Scott KA, Wilson JL, Thompson
RG, Proudfoot AE and Balkwill FR: A chemokine receptor antagonist
inhibits experimental breast tumor growth. Cancer Res.
63:8360–8365. 2003.PubMed/NCBI
|
|
12
|
Ng-Cashin J, Kuhns JJ, Burkett SE,
Powderly JD, Craven RR, van Deventer HW, Kirby SL and Serody JS:
Host absence of CCR5 potentiates dendritic cell vaccination. J
Immunol. 170:4201–4208. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
van Deventer HW, O'Connor W Jr, Brickey
WJ, Aris RM, Ting JP and Serody JS: C-C chemokine receptor 5 on
stromal cells promotes pulmonary metastasis. Cancer Res.
65:3374–3379. 2005.PubMed/NCBI
|
|
14
|
Son JH, Kong TW, Kim SH, Paek J, Chang SJ,
Lee EJ and Ryu HS: Prediction of lymph node metastasis in patients
with apparent early endometrial cancer. Obstet Gynecol Sci.
58:385–390. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang J, He Q, Shao YG and Ji M: Chemokines
fluctuate in the progression of primary breast cancer. Eur Rev Med
Pharmacol Sci. 17:596–608. 2013.PubMed/NCBI
|
|
16
|
Lin S, Wan S, Sun L, Hu J, Fang D, Zhao R,
Yuan S and Zhang L: Chemokine C-C motif receptor 5 and C-C motif
ligand 5 promote cancer cell migration under hypoxia. Cancer Sci.
103:904–912. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mango RL, Wu QP, West M, McCook EC, Serody
JS and van Deventer HW: C-C chemokine receptor 5 on pulmonary
mesenchymal cells promotes experimental metastasis via the
induction of erythroid differentiation regulator 1. Mol Cancer Res.
12:274–282. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Singh H, Sachan R, Jain M and Mittal B:
CCR5-Delta32 polymorphism and susceptibility to cervical cancer,
Association with early stage of cervical cancer. Oncol Res.
17:87–91. 2008.PubMed/NCBI
|
|
19
|
Wang L, Chang L, Li Z, Gao Q, Cai D, Tian
Y, Zeng L and Li M: miR-99a and −99b inhibit cervical cancer cell
proliferation and invasion by targeting mTOR signaling pathway. Med
Oncol. 31:9342014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wen SY, Lin Y, Yu YQ, Cao SJ, Zhang R,
Yang XM, Li J, Zhang YL, Wang YH, Ma MZ, et al: miR-506 acts as a
tumor suppressor by directly targeting the hedgehog pathway
transcription factor Gli3 in human cervical cancer. Oncogene.
34:717–725. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou C, Li G, Zhou J, Han N, Liu Z and Yin
J: miR-107 activates ATR/Chk1 pathway and suppress cervical cancer
invasion by targeting MCL1. PLoS One. 9:e1118602014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Roldo C, Missiaglia E, Hagan JP, Falconi
M, Capelli P, Bersani S, Calin GA, Volinia S, Liu CG, Scarpa A, et
al: MicroRNA expression abnormalities in pancreatic endocrine and
acinar tumors are associated with distinctive pathologic features
and clinical behavior. J Clin Oncol. 24:4677–4684. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takahashi Y, Forrest AR, Maeno E,
Hashimoto T, Daub CO and Yasuda J: MiR-107 and MiR-185 can induce
cell cycle arrest in human non small cell lung cancer cell lines.
PLoS One. 4:e66772009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Martello G, Rosato A, Ferrari F, Manfrin
A, Cordenonsi M, Dupont S, Enzo E, Guzzardo V, Rondina M, Spruce T,
et al: A microRNA targeting dicer for metastasis control. Cell.
141:1195–1207. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li F, Liu B, Gao Y, Liu Y, Xu Y, Tong W
and Zhang A: Upregulation of microRNA-107 induces proliferation in
human gastric cancer cells by targeting the transcription factor
FOXO1. FEBS Lett. 588:538–544. 2014. View Article : Google Scholar : PubMed/NCBI
|
